89 results
Page 3 of 5
8-K
EX-99.2
86e1n rq9
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
t5elhdt60 yhaizfcda9
13 Mar 20
Regulation FD Disclosure
9:06am
8-K
EX-99.1
dj0 jgiuu9bvkx1hlqr
2 Mar 20
Regulation FD Disclosure
3:48pm
424B5
pbcyusuoud00at2
12 Nov 19
Prospectus supplement for primary offering
8:02am
424B5
2t91co7
7 Oct 19
Prospectus supplement for primary offering
9:35pm
424B5
lhl9 i4wm
7 Oct 19
Prospectus supplement for primary offering
9:33pm
8-K
EX-1.1
n40vtxnyemwl
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-1.2
19trvo
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
424B5
wnn34
3 Oct 19
Prospectus supplement for primary offering
4:11pm
424B5
j7auyde7gm5
3 Oct 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
hdqpup
9 Sep 19
Other Events
12:00am
8-K
EX-99.1
j4yneyyp b46c991r
27 Jun 19
Regulation FD Disclosure
12:04pm